Observatory on Artificial Labour-induction Methods and Measuring Immediate Postpartum Maternal Satisfaction (SATISFACC)

February 11, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Observatory on Different Artificial Labour-induction Methods and Measuring Immediate Postpartum Maternal Satisfaction

Our hypothesis is that there is one sequence of labour-induction that leads to a better experience of childbirth than others. This is based on the following underlying theories :

  • Maternal satisfaction depends on the number of labour-inducing sequences
  • A longer labour-induction would be experienced less positively than a shorter one
  • The experience is correlated with maternal outcomes ( vaginal / Caesarian delivery, spontaneous birth or instrument-assisted birth, maternal complications ) and neonatal outcomes (neonatal complications, secondary hospitalization).

Study Overview

Status

Completed

Conditions

Detailed Description

Artificial labour induction is a medical intervention used in the interest of the mother or unborn child, aimed at provoking birth by inducing uterine contractions artificially, leading to cervical effacement and dilation. The purpose is to end the pregnancy in the interest of the mother and/or foetus.

According to the latest results of the Perinatal Enquiry (2016), induced labour rates total around 22% of pregnancies (767.000 births in 2017) in all maternity clinics. For the university hospitals of Nimes and Montpellier, with Level 3 maternity units (thus requiring a higher rate of inductions), this represents 515 and 550 pregnancies respectively (2017 figures).

There are several methods of inducing labour: use of a cervical ripening balloon (a medical device with which the onset of labour is provoked mechanically), vaginal inserts containing prostaglandins or intravenous perfusion with oxytocin combined with water-breakage. These labour-induction methods may be used alone or in succession depending on the evaluation of the cervix using the Bishop score as a reference. Each method has its own benefits and risks.

There is variability between establishments in the protocols used for cervical ripening.

The Nimes and Montpellier centres both use the same methods, but with different sequences.

Studies are mainly devoted to evaluating each method individually in terms childbirth by vaginal delivery and duration of labour.

Maternal satisfaction, which is a rarely studied multifactorial evaluation, is correlated with women's psychological outcome. A bad experience during childbirth appears to increase the risk of post-partum (PP) psychological disorders.

Considering the current literature available, although there have been trials comparing two isolated labour-induction methods, like the study by Probaat (Jozwiak et al., 2013), which compared obstetrical and neonatal outcomes with the cervical ripening balloon and the prostaglandin insert, none of these studies investigated their impact on maternal satisfaction. Although there have been a few studies evaluating maternal satisfaction at childbirth, there have not been any evaluating satisfaction during artificial labour-induction in a pragmatic situation.

The aim of our study was therefore to evaluate the impact on semi-immediate maternal satisfaction under pragmatic, real-life conditions depending on the various possible induction scenarios (both in terms of the number of methods used, from 1 to 3, and the possible combinations when at least 2 or more methods were used ).

Study Type

Observational

Enrollment (Actual)

260

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gard
      • Nîmes, Gard, France, 30029
        • Centre Hospitalier Universitaire
    • Hérault
      • Montpellier, Hérault, France, 34090
        • CHU Arnaud de Villeneuve Service de Gynécologie Obstétrique

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Women 18+ admitted to gynecology-obstetric depts. of Montpellier & Nîmes University Hospitals for artificial labor-induced childbirth. Sociodemographic and medical variables will be noted: patient's knowledge of labor-induction, labor in childbirth, age, weight, height (BMI), no. of previous pregnancies, childbirths, miscarriages, abortions, medically-motivated induced terminations, medical antecedents (comorbidities), important surgery (esp. uterine), ongoing treatment, tobacco/alcohol/cannabis intake, Down's syndrome screening, pregnancy particularities (medically-assisted procreation), antenatal diagnosis, no. of hospital consultations, gestational age at admission, information received, other newborn data (term, weight, size, cranial perimeter at birth), reason for induction.

Description

Inclusion Criteria:

The patient has made no formal opposition to taking part in the study.

  • The patient must be affiliated to/have the benefit of a health insurance scheme.
  • The patient is at least 18 years old.
  • The patient is capable of understanding the instructions required for answering questionnaires in French.

Concerning the targeted population:

  • The patient has a medical indication for labour-induction.
  • Term ≥ 37 weeks.
  • The foetus is alive and viable, without any known lethal pathology

Exclusion Criteria:

The person is in a period of exclusion determined by a previous study.

  • The person has been placed under judicial protection and is under guardianship or curatorship.
  • It is impossible to give the person accurate information.

Non-inclusion criteria concern associated illnesses or interfering conditions:

  • The patient does not have the possibility to answer the questionnaire at 1 month
  • Contra-indication for labour-induction or vaginal delivery
  • Foetal presentation other than cephalic.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall patient satisfaction
Time Frame: 2 hours after giving birth
Overall patient satisfaction evaluated via a 4-point Likert scale (1= not satisfied, 2 = moderately satisfied, 3 = satisfied, 4 = very satisfied) on a touchscreen.
2 hours after giving birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction evaluated via the W-DEQ questionnaire
Time Frame: 2 hours after giving birth
The Wijma Delivery Experience Questionnaire (W-DEQ) is a Scandinavian questionnaire (designed by Wijma et al. in 1998) translated into French. It evaluates the patient's true experience of childbirth compared with her expectations. It has 33 items based on recurring fears of pregnant women, divided into several catégories (fear, negative feelings, lack of confidence, behaviour etc…).
2 hours after giving birth
Post-partum QEVA satisfaction questionnaire
Time Frame: 1-2 months after giving birth
The pluridimensional Questionnaire d'Evaluation du Vécu de l'Accouchement (QEVA) known in English as the QACE (Questionnaire for Assessing the Childbirth Experience is used to evaluate the patient's experience of childbirth. It contains 25 items, each with a 4-point Likert scale, divided into the following categories: relationship with healthcare teams, emotions (positive and negative), first moments with the newborn baby, situation one month after childbirth. An e-mail is sent to the patient 1 month after giving birth, asking her to complete the QEVA by logging onto a dedicated platform.
1-2 months after giving birth
Different methods of labour-induction used
Time Frame: 6 months after giving birth
Data collection from medical files on the methods of labour-induction used (alone or successively), duration of use and intermediate Bishop scores. This a pre-labor scoring system reflecting cervical modification ranges from 0 to 3 (0= cervix closed and 3 = dilated to more than 5 cm) assists in predicting whether labour-induction will be required and the likelihood of spontaneous preterm delivery.
6 months after giving birth
Spontaneous vaginal deliveries
Time Frame: 48 hours maximum
Rate of spontaneous vaginal deliveries,
48 hours maximum
Rate of instrument-assisted vaginal deliveries
Time Frame: 48 hours maximum
Rate of instrument-assisted vaginal deliveries.
48 hours maximum
Reason for instrument-assisted vaginal deliveries
Time Frame: 48 hours maximum
Reason for instrument-assisted vaginal deliveries (non progression of fœtal presentation, fœtal distress, maternal complications).
48 hours maximum
Type of instrument-assisted vaginal deliveries
Time Frame: 48 hours maximum

Type of instrumental extraction used for the delivery

.

48 hours maximum
Rate of Caesarian births
Time Frame: 48 hours maximum
Rate of Caesarian births and reason (no cervical dilatation at the first stage of labour : dilatation 0 to 10cm, absence of fœtal descent at stage 2 of labour, fœtal cause, maternal cause).
48 hours maximum
Reason for Caesarian births
Time Frame: 48 hours maximum
Reason for Caesarian birth (no cervical dilatation at the first stage of labour : dilatation 0 to 10cm, absence of fœtal descent at stage 2 of labour, fœtal cause, maternal cause).
48 hours maximum
Time from start of labour-induction to start of labour
Time Frame: 48 hours maximum
Time between the start of labour-induction and the onset of labour will be measured
48 hours maximum
Time from labour-induction to birth (Caesarian births excluded),
Time Frame: 48 hours maximum
Time from labour-induction to vaginal delivery
48 hours maximum
Vaginal deliveries at H12
Time Frame: 12 hours from start of induction
Rate of vaginal deliveries at 12 hours from start of labour-induction
12 hours from start of induction
Vaginal deliveries at H24
Time Frame: 24 hours from start of induction
Rate of vaginal deliveries at 24 hours from start of labour-induction
24 hours from start of induction
Vaginal deliveries at H48
Time Frame: 48 hours from start of induction
Rate of vaginal deliveries at 48 hours from start of labour-induction
48 hours from start of induction
Labour-induction failures
Time Frame: 12 - 18 hours
Rate of labour-induction failures giving rise to a Caesarian due to the duration of the latency phase (0-6cm) ≥24h with oxytocine administered for at least 12-18h after artificial water-breakage.
12 - 18 hours
Propess
Time Frame: up to 48 hours before birth
Rate of secondary or tertiary use of Propess (vaginal prostaglandine inserts)
up to 48 hours before birth
Balloon/Foley bulb
Time Frame: 48 hours maximum
Rate of secondary or tertiary use of the cervical ripening balloon (Foley bulb)
48 hours maximum
Oxytocine
Time Frame: 48 hours maximum
Rate of secondary or tertiary use of intravenous Oxytocine
48 hours maximum
Epidurals
Time Frame: 48 hours maximum
Rate of epidural anesthaesia during labour
48 hours maximum
Bishop score evolution: Propess
Time Frame: Until birth (48 hours maximum)
The Bishop score,developed by Professor Emeritus of Obstetrics and Gynecology Dr. Edward Bishop, is also known as cervix score. It is a pre-labor scoring system to assist in predicting whether induction of labor will be required. It is based on 5 points : Cervical dilation in centimeters, cervical effacement as a percentage,cervical consistency by provider assessment/judgement, cervical position, fetal station (the position of the fetal head in relation to the pelvic bones).The Bishop score grades patients who would be most likely to achieve a successful induction. The duration of labor is inversely correlated with the Bishop score; a score that exceeds 8 describes the patient most likely to achieve a successful vaginal birth. Bishop scores of less than 6 usually require a cervical ripening method (pharmacologic or physical, such as a Foley bulb).
Until birth (48 hours maximum)
Bishop score evolution: Balloon/Foley bulb
Time Frame: Until birth (48 hours maximum)
The Bishop score,developed by Professor Emeritus of Obstetrics and Gynecology Dr. Edward Bishop, is also known as cervix score. It is a pre-labor scoring system to assist in predicting whether induction of labor will be required. It is based on 5 points : Cervical dilation in centimeters, cervical effacement as a percentage,cervical consistency by provider assessment/judgement, cervical position, fetal station (the position of the fetal head in relation to the pelvic bones).The Bishop score grades patients who would be most likely to achieve a successful induction. The duration of labor is inversely correlated with the Bishop score; a score that exceeds 8 describes the patient most likely to achieve a successful vaginal birth. Bishop scores of less than 6 usually require a cervical ripening method (pharmacologic or physical, such as a Foley bulb).
Until birth (48 hours maximum)
Bishop score evolution: Ocytocine
Time Frame: Until birth (48 hours maximum)
The Bishop score,developed by Professor Emeritus of Obstetrics and Gynecology Dr. Edward Bishop, is also known as cervix score. It is a pre-labor scoring system to assist in predicting whether induction of labor will be required. It is based on 5 points : Cervical dilation in centimeters, cervical effacement as a percentage,cervical consistency by provider assessment/judgement, cervical position, fetal station (the position of the fetal head in relation to the pelvic bones).The Bishop score grades patients who would be most likely to achieve a successful induction. The duration of labor is inversely correlated with the Bishop score; a score that exceeds 8 describes the patient most likely to achieve a successful vaginal birth. Bishop scores of less than 6 usually require a cervical ripening method (pharmacologic or physical, such as a Foley bulb).
Until birth (48 hours maximum)
Maternal morbidity
Time Frame: 6 months after giving birth
Rate of uterine hyperstimulation(> 6 contractions in 10 minutes on 2 occasions) with or without an effect on the foetus
6 months after giving birth
Maternal morbidity
Time Frame: 48 hours maximum
Rate of uterine hypertonia (contraction > 2 minutes with slowing down of fœtal heartbeat)
48 hours maximum
Maternal morbidity: moderate haemorrhage
Time Frame: 48 hours maximum
Rate of post partum haemorrage ≥ 500ml, rate of severe post-partum haemorrhage ≥1000ml, rate of transfusion, number of packs of red blood cells transfused
48 hours maximum
Maternal morbidity: severe haemorrage
Time Frame: 48 hours maximum
rate of severe post-partum haemorrage ≥1000ml rate of transfusion, number of packs of red blood cells transfused
48 hours maximum
Maternal morbidity: transfusion rate
Time Frame: 48 hours maximum
Rate of transfusions
48 hours maximum
Maternal morbidity: amount of blood transfused
Time Frame: 48 hours maximum
This is measured in terms of the number of packs of red blood cells transfused
48 hours maximum
Maternal morbidity: rupture
Time Frame: 48 hours maximum
Rate of uterine rupture
48 hours maximum
Maternal morbidity: Chorioamniotitis
Time Frame: 48 hours maximum
Chorioamniotitis (temperature > 38°C with fœtal tachycardia > 160 beats / minute)
48 hours maximum
Maternal morbidity: infection
Time Frame: 1 week after giving birth
Rate of post-partum infection (temperature > 38°C with antibiotherapy, urinary infection, bacteriologically-proven endometritis at 1 week post-partum)
1 week after giving birth
Neonatal morbidity:asphyxia
Time Frame: 5 minutes after giving birth
Rate of neonatal asphyxia (umbilical cord arterial pH ≤ 7.05, and/or APGAR at 5 minutes < 7). The Apgar score is a means of evaluating the vitality of a newborn based on the simple observation at the time of birth. The value is a prognostic for neonatal mortality. It was developed in 1952 by the American doctor, Virginia Apgar.
5 minutes after giving birth
Neonatal morbidity: neonatal hospitalisation
Time Frame: up to 48 hours after giving birth
Rate of neonatal pediatric hospitalisations
up to 48 hours after giving birth
Neonatal morbidity: infection
Time Frame: up to 48 hours after giving birth
Bacteriologically-proven infection rate
up to 48 hours after giving birth
Maternal tolerance: bleeding
Time Frame: up to 48 hours after giving birth
Metrorrhagia due to vaginal insert (dinoprostone) or cervical ripening balloon placement
up to 48 hours after giving birth
Maternal tolerance: pain due to overinflation of the balloon (Foley bulb)
Time Frame: up to 48 hours after giving birth
Pain related to balloon inflation requiring secondary partial deflation, reorded with a VAS. The visual analog scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.The pain VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity
up to 48 hours after giving birth
Maternal tolerance: pain on 1st induction sequence
Time Frame: up to 48 hours before birth
Pain level recorded with a VAS before the 1st induction sequence. The visual analog scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.The pain VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity
up to 48 hours before birth
Maternal tolerance: pain after childbirth
Time Frame: 2 hours after giving birth
Pain level recorded with a VAS at H2 of childbirth.
2 hours after giving birth
Maternal tolerance: pain during childbirth
Time Frame: labour time
Pain level at various times of labour-induction recorded with a VASThe visual analog scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.The pain VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity
labour time
Maternal tolerance: pain due to insert or balloon (Foley bulb)
Time Frame: up to 48 hours before birth
Pain level recorded with a VAS before vaginal insert or balloon placement. The visual analog scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.The pain VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity
up to 48 hours before birth
Maternal tolerance: pain due to insert or balloon (Foley bulb) at H2
Time Frame: 2 hours after device placement
Pain level recorded with a VAS 2 hours after vaginal insert or balloon placement. The visual analog scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.The pain VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity
2 hours after device placement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: vincent letouzey, M., CHU de Nîmes Service de Gynécologie Obstétrique

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2019

Primary Completion (Actual)

January 9, 2024

Study Completion (Actual)

January 9, 2024

Study Registration Dates

First Submitted

August 29, 2019

First Submitted That Met QC Criteria

August 29, 2019

First Posted (Actual)

September 3, 2019

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NIMAO/2018-03/BC-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Induction

Subscribe